SLP-2 is required for stress-induced mitochondrial hyperfusion
Creators
- Tondera, Daniel1, 2
- Grandemange, Stephanie1, 3
- Jourdain, Alexis1
- Karbowski, Mariusz
- Mattenberger, Yves1
- Herzig, Sebastien1
- Da Cruz, Sandrine1, 4
- Clerc, Pascaline5
- Raschke, Ines6
- Merkwirth, Carsten6
- Ehses, Sarah6
- Krause, Frank7
-
Chan, David C.8
- Alexander, Christiane9
- Bauer, Christoph1
- Youle, Richard5
- Langer, Thomas6
- Martinou, Jean-Claude1
-
1.
University of Geneva
-
2.
Dana-Farber Cancer Institute
-
3.
University of Lorraine
-
4.
University of California, San Diego
-
5.
National Institute of Neurological Disorders and Stroke
-
6.
University of Cologne
-
7.
TU Darmstadt
-
8.
California Institute of Technology
-
9.
Max Delbrück Center for Molecular Medicine
Abstract
Mitochondria are dynamic organelles, the morphology of which results from an equilibrium between two opposing processes, fusion and fission. Mitochondrial fusion relies on dynamin-related GTPases, the mitofusins (MFN1 and 2) in the outer mitochondrial membrane and OPA1 (optic atrophy 1) in the inner mitochondrial membrane. Apart from a role in the maintenance of mitochondrial DNA, little is known about the physiological role of mitochondrial fusion. Here we report that mitochondria hyperfuse and form a highly interconnected network in cells exposed to selective stresses. This process precedes mitochondrial fission when it is triggered by apoptotic stimuli such as UV irradiation or actinomycin D. Stress-induced mitochondrial hyperfusion (SIMH) is independent of MFN2, BAX/BAK, and prohibitins, but requires L-OPA1, MFN1, and the mitochondrial inner membrane protein SLP-2. In the absence of SLP-2, L-OPA1 is lost and SIMH is prevented. SIMH is accompanied by increased mitochondrial ATP production and represents a novel adaptive pro-survival response against stress.
Additional Information
© 2009 European Molecular Biology Organization. Received: 24 November 2008; accepted: 12 March 2009; published online: 9 April 2009. We thank Dr Mihara and Dr Ishihara for rat OPA1-V1, OPA1-V1DS1, OPA1-V7, and AIF-OPA1-V7230–997 cDNAs, Dr Scorrano for OPA1 cDNA, Dr Rojo for human Mfn1 cDNA, Professor Wiesner for 143B rho0 cells, Professor Picard for pdtTomato-C1, Dr Dencher and Dr Madrenas for support, Dr Rossignol for his advices and all members of the lab for fruitful discussions. This work was funded by the Deutsche Forschungsgemeinschaft (DFG) (TO540/1-1), the NIH intramural program, the Swiss National Science Foundation (subsidy 3100A0-109419/1), Oncosuisse Trust, Roche Research Foundation and the Geneva Department of Education. FK is funded in part by the European Union (MiMage, EC FP6 Contract No. LSHM-CT-2004-512020).Additional details
Identifiers
- PMCID
- PMC2693158
- Eprint ID
- 15560
- DOI
- 10.1038/emboj.2009.89
- Resolver ID
- CaltechAUTHORS:20090903-083208055
Related works
- Describes
- 10.1038/emboj.2009.89 (DOI)
Funding
- Deutsche Forschungsgemeinschaft (DFG)
- TO540/1-1
- NIH
- Swiss National Science Foundation
- 3100A0-109419/1
- Oncosuisse Trust
- Roche Reasearch Foundation
- Geneva Department of Education
- European Union
- LSHM-CT-2004-512020
Dates
- Created
-
2009-09-22Created from EPrint's datestamp field
- Updated
-
2021-11-08Created from EPrint's last_modified field